AQR Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $104M | Sell |
|
|||||
2025
Q1 | $151M | Sell |
|
|||||
2024
Q4 | $178M | Buy |
|
|||||
2024
Q3 | $48.5M | Buy |
|
|||||
2024
Q2 | $17.1M | Buy |
|
|||||
2024
Q1 | $16.7M | Sell |
|
|||||
2023
Q4 | $50.1M | Sell |
|
|||||
2023
Q3 | $169M | Sell |
|
|||||
2023
Q2 | $196M | Sell |
|
|||||
2023
Q1 | $380M | Sell |
|
|||||
2022
Q4 | $503M | Sell |
|
|||||
2022
Q3 | $468M | Buy |
|
|||||
2022
Q2 | $554M | Sell |
|
|||||
2022
Q1 | $554M | Buy |
|
|||||
2021
Q4 | $404M | Buy |
|
|||||
2021
Q3 | $243M | Buy |
|
|||||
2021
Q2 | $210M | Buy |
|
|||||
2021
Q1 | $192M | Buy |
|
|||||
2020
Q4 | $156M | Sell |
|
|||||
2020
Q3 | $290M | Sell |
|
|||||
2020
Q2 | $325M | Sell |
|
|||||
2020
Q1 | $361M | Sell |
|
|||||
2019
Q4 | $517M | Buy |
|
|||||
2019
Q3 | $466M | Sell |
|
|||||
2019
Q2 | $836M | Sell |
|
|||||
2019
Q1 | $1.05B | Sell |
|
|||||
2018
Q4 | $1.19B | Buy |
|
|||||
2018
Q3 | $1.02B | Buy |
|
|||||
2018
Q2 | $526M | Sell |
|
|||||
2018
Q1 | $569M | Sell |
|
|||||
2017
Q4 | $691M | Sell |
|
|||||
2017
Q3 | $745M | Buy |
|
|||||
2017
Q2 | $491M | Buy |
|
|||||
2017
Q1 | $372M | Buy |
|
|||||
2016
Q4 | $335M | Buy |
|
|||||
2016
Q3 | $330M | Buy |
|
|||||
2016
Q2 | $278M | Sell |
|
|||||
2016
Q1 | $240M | Sell |
|
|||||
2015
Q4 | $563M | Buy |
|
|||||
2015
Q3 | $531M | Buy |
|
|||||
2015
Q2 | $478M | Buy |
|
|||||
2015
Q1 | $450M | Sell |
|
|||||
2014
Q4 | $434M | Buy |
|
|||||
2014
Q3 | $309M | Buy |
|
|||||
2014
Q2 | $309M | Buy |
|
|||||
2014
Q1 | $303M | Buy |
|
|||||
2013
Q4 | $238M | Buy |
|
|||||
2013
Q3 | $198M | Sell |
|
|||||
2013
Q2 | $303M | Buy |
|